| Literature DB >> 32479770 |
Shirley Sze1, Daniel Pan2, Caroline M L Williams2, Nicholas Wong3, Amandip Sahota3, David Bell3, Julian W Tang4, Martin Wiselka3, Iain Stephenson3, Manish Pareek5.
Abstract
Entities:
Mesh:
Year: 2020 PMID: 32479770 PMCID: PMC7258849 DOI: 10.1016/j.jinf.2020.05.063
Source DB: PubMed Journal: J Infect ISSN: 0163-4453 Impact factor: 6.072
Fig. 1NEWS2 scores of all patients with COVID-19, stratified by admission NEWS2 score.
Baseline characteristics compared those who died vs those who survived.
| Died (N=10) | Survived (N=7) | P value (Died vs Survived) | |
|---|---|---|---|
| Age | 86 (83-88) | 83 (82-88) | 0.59 |
| Sex (male), N (%) | 7 (70) | 2 (29) | 0.09 |
| Ethnicity, N (%) | 0.68 | ||
| Caucasian | 8 (80) | 6 (86) | |
| Asian Indian | 1 (10) | 1 (14) | |
| Black | 1 (10) | 0 | |
| 0 | 0 | 1 (14) | 0.46 |
| 1-2 | 3 (30) | 2 (29) | |
| 3+ | 7 (70) | 4 (57) | |
| Ischaemic heart disease, N (%) | 1 (10) | 0 | 0.39 |
| Peripheral vascular disease, N (%) | 1 (10) | 2 (29) | 0.32 |
| Stroke, N (%) | 2 (20) | 1 (14) | 0.76 |
| Hypertension, N (%) | 6 (60) | 1 (14) | 0.06 |
| Atrial fibrillation, N (%) | 1 (10) | 2 (29) | 0.32 |
| Heart failure, N (%) | 1 (10) | 4 (57) | 0.04 |
| Diabetes, N (%) | 2 (20) | 1 (14) | 0.76 |
| Dementia, N (%) | 2 (20) | 1 (14) | 0.76 |
| Chronic kidney disease, N (%) | 1 (10) | 0 | 0.39 |
| Cancer, N (%) | 4 (40) | 1 (14) | 0.25 |
| COPD, N (%) | 2 (20) | 3 (43) | 0.31 |
| Obstructive sleep apnoea, N (%) | 2 (20) | 0 | 0.21 |
| Clinical frailty scale | 6 (5-7) | 6 (4-7) | 0.65 |
| NEWS2 | 5 (0-8) | 3 (2-6) | 0.92 |
| Respiratory rate (breaths/min) | 21 (18-28) | 24 (20-28) | 0.69 |
| O2 saturation (%) | 96 (92-97) | 96 (93-98) | 0.96 |
| FiO2 (%) | 28 (21-100) | 21 (21-21) | 0.09 |
| Systolic blood pressure (mmHg) | 129 (124-133) | 146 (141-157) | |
| Diastolic blood pressure (mmHg) | 74 (58-84) | 81 (66-98) | 0.26 |
| Heart rate (beats per minute) | 81 (74-95) | 84 (79-86) | 0.53 |
| Temperature (degree celcius) | 37.5 (36.8-38.5) | 37.4 (36.8-38.1) | 0.70 |
| Fever, N (%) | 8 (80) | 2 (29) | |
| Cough, N (%) | 3 (30) | 5 (71) | 0.09 |
| Breathlessness, N (%) | 5 (50) | 4 (57) | 0.77 |
| Diarrhoea, N (%) | 0 | 3 (43) | |
| Confusion, N (%) | 2 (20) | 2 (29) | 0.68 |
| Falls, N (%) | 1 (10) | 0 | 0.39 |
| White cell count (x109/L) | 8.5 (3.7-15.9) | 7.3 (2.3-9.1) | 0.38 |
| Neutrophils (x109/L) | 6.8 (2.8-13.6) | 5.1 (1.8-8.0) | 0.33 |
| Lymphocyte (x109/L) | 0.99 (0.63-1.48) | 0.63 (0.31-1.07) | 0.14 |
| Haemoglobin (g/L) | 125 (113-142) | 116 (102-119) | 0.22 |
| Platelets (x109/L) | 173 (114-260) | 206 (135-261) | 0.38 |
| C-reactive protein (mg/L) | 65 (33-156) | 31 (9-110) | 0.24 |
| Sodium (mmol/L) | 133 (131-137) | 136 (131-138) | 0.46 |
| Potassium (mmol/L) | 4.7 (4.2-5.1) | 3.9 (3.4-4.4) | |
| Urea (mmol/L) | 9.2 (7.0-15.9) | 7.2 (3.0-10.5) | 0.28 |
| Creatinine (µmol/L) | 122 (87-168) | 91 (57-119) | 0.12 |
| Total number during admission | 2 (1-3) | 1 (1-1) | 0.12 |
| Clear | 3 (30) | 4 (57) | |
| Unilateral consolidation | 0 | 3 (43) | |
| Bilateral consolidation | 7 (70) | 0 | |
| 22.51 (17.96-27.46) | 25.12 (18.54-31.04) | 0.40 | |
| Oxygen therapy, N (%) | 10 (100) | 3 (43) | |
| Nasal canulae, N (%) | 9 (90) | 3 (43) | |
| Non-rebreathe mask, N (%) | 9 (90) | 0 | |
| High-flow oxygen, N (%) | 3 (30) | 0 | 0.11 |
| Non-invasive ventilation, N (%) | 2 (20) | 0 | 0.21 |
| Length of stay (days) | 6 (4-13) | 9 (7-10) | 0.13 |